Roasted Pulse Snacks, Post-prandial Food Intake, Appetite, and Glycemia

A Comparison of Roasted Pulse Snacks on Post-prandial Food Intake, Appetite, and Glycemic Response in Healthy Young Adults

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03223935

Enrollment

Registered

2017-07-21

Start date

2017-08-11

Completion date

2018-04-04

Last updated

2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Weight, Overweight, Normoglycemic

Brief summary

An investigation on the effects of roasted pulse snacks on post-prandial glycemic and satiety response in healthy young adults.

Detailed description

An acute, randomized, controlled cross-over trial examining the post-prandial glycemic and satiety response to six snacks will be conducted. The study treatments are: 1) roasted corn nuts, 2) roasted chickpeas, 3) roasted yellow peas, 4) roasted pinto beans 5) roasted soybeans, and 6) roasted almonds. They will be matched for calorie content and provided in 200 kcal servings.

Interventions

OTHERCorn nuts

Roasted corn nut snack

OTHERChickpeas

Roasted chickpea snack

OTHERYellow peas

Roasted yellow pea snack

OTHERPinto beans

Roasted pinto bean snack

OTHERSoybeans

Roasted soybean snack

OTHERAlmonds

Roasted almond snack

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

OTHER

Masking

NONE

Intervention model description

Randomized, controlled cross-over acute trial

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* BMI: ≥18.5 and ≤29.9 kg/m2 * Fasting serum glucose: ≤5.5 mmol/L

Exclusion criteria

* Fasting serum glucose \> 5.5 mmol/L * Smoking * Thyroid problems * Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease * Presence of a gastrointestinal disorder or surgeries within the past year * Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgment * Known to be pregnant or lactating * Known intolerance, sensitivity or allergy to any ingredients in the study products. * Extreme dietary habits (i.e. Atkins diet, very high protein diets, etc.) * Uncontrolled hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) * Weight gain or loss of at least 10lbs in previous three months * Excessive alcohol intake * Restrained Eaters (identified by Eating Habits Questionnaire)

Design outcomes

Primary

Measure	Time frame	Description
Food intake	At 60 min	Ab libitum meal

Secondary

Measure	Time frame	Description
Blood glucose concentrations	0-200 min	Measured in blood using a glucometer at 12 time points and used to calculate area under the curve
Physical comfort	0-200 min	Measured by VAS questionnaire at 12 time points to calculate area under the curve
Subjective appetite	0-200 min	Measured by VAS questionnaire at 12 time points used to calculate area under the curve
Palatability of meal	At 60 min	Measured by VAS questionnaire
Palatability of treatment	At 5 min	Measured by VAS questionnaire
Energy and fatigue	0-200 min	Measured by VAS questionnaire at 12 time points to calculate area under the curve

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026